Cargando…
Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors. The first molecular targeted treatment
Chronic Myeloid Leukemia is the first malignant disorder with a specific genetic abnormality in the background. Known as a disease with an inexorable progression to acute leukemia for many years, its natural history has been dramatically improved by the use of tyrosine kinase inhibitors (TKI). They...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Carol Davila University Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019054/ https://www.ncbi.nlm.nih.gov/pubmed/20968202 |